Application of Magnetic Resonance Fat-Free Imaging
NCT00944476 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 2
Last updated 2014-05-15
Summary
Magnetic resonance imaging (MRI) is presently the best study for assessing the size and extent of the patient's sarcoma. Many sarcomas contain fat that can interfere with the accuracy of sarcoma detection. The investigators have developed a new MRI method that can suppress all the fat signals in the patient's tumor and this may improve the investigators' ability to see the patient's sarcoma. The purpose of this study is to determine if the investigators' new fat-free imaging methods provides them with images that are better than, equal to, or worse than those images obtained by standard MRI methods. This study may help the investigators develop a more accurate MRI examination.
Conditions
- Sarcoma
Interventions
- PROCEDURE
-
Fat-free MRI images utilizing standard magnetization, Questionnaire before the MRI exam
In addition to the traditional MRI exam for clinical use, a fat-free MRI based on standard magnetization transfer magnetic resonance imaging will be acquired. Pts will spend 20 extra minutes and 20 minutes total for volunteers in the MRI scanner. Patients/volunteers will complete the MR Screening Questionnaire before the MRI exam.
Sponsors & Collaborators
-
Memorial Sloan Kettering Cancer Center
lead OTHER
Principal Investigators
-
Samuel Singer, MD · Memorial Sloan Kettering Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-07-31
- Primary Completion
- 2014-05-31
Countries
- United States
Study Locations
More Related Trials
-
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
NCT07118176 ·Status: RECRUITING ·Phase: PHASE1
-
[18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors
NCT00832598 ·Status: COMPLETED ·Phase: NA
-
Application of 18F-FDG PET/MRI for Initial Staging in Locally Advanced Nasopharyngeal Carcinoma
NCT06947759 ·Status: NOT_YET_RECRUITING
-
A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes.
NCT01083719 ·Status: UNKNOWN ·Phase: PHASE2
-
Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5
NCT00743353 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
PET Imaging of Intracranial Cancers With 18F-FSPG
NCT02370563 ·Status: TERMINATED ·Phase: PHASE1
-
7T MRI Scan for the Early Detection of Melanoma Brain Metastases
NCT04941430 ·Status: TERMINATED ·Phase: NA
-
Evaluation of PET/MR and PET/CT Imaging for Bone Marrow Lesions
NCT01880762 ·Status: COMPLETED
-
18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases
NCT04752267 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Whole-Body MRI and Conventional Imaging in Detecting Distant Metastases in Young Patients With Solid Tumors or Lymphoma
NCT00072488 ·Status: UNKNOWN ·Phase: NA
-
Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers
NCT04459273 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Intraoperative Imaging of a PET Positive Lymph Node(s) Using 18FDG and a Dual-Mode, Hand-Held Intraoperative Imager
NCT03561324 ·Status: WITHDRAWN ·Phase: NA
-
Detection of Cervical Lymph Node Metastases With a High-Resolution Positron Emission Tomography (PET) Imaging System
NCT01030497 ·Status: COMPLETED
-
MRI FDG PET Imaging Cervix
NCT01899404 ·Status: COMPLETED ·Phase: NA
-
18F-DCFPyL PET/MRI in Regional Nodal&Distant Metastases Detection in Intermediate &HR Prostate Cancer
NCT04809584 ·Status: APPROVED_FOR_MARKETING
-
Combined CT Colonography and PET Imaging in Mantle Cell Lymphoma
NCT00541424 ·Status: WITHDRAWN
-
Evaluation of 18F-fluciclovine (FACBC) PET/MR Uptake in Participants With Glioma
NCT04114370 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
PET/MR in Assessing Response to Neoadjuvant Radiation Therapy in the Tx of High Grade Sarcomas
NCT03076333 ·Status: COMPLETED ·Phase: NA
-
Clinical Application of 18F-PFPN PET Imaging in Diagnosis and Staging of Clear Cell Sarcoma of Soft Tissue
NCT05963035 ·Status: UNKNOWN ·Phase: NA
-
Whole Body Magnetic Resonance Imaging (MRI) for Detection of Cancer Metastases
NCT00592462 ·Status: COMPLETED
-
Functional Imaging of Tumor and Normal Tissue
NCT00933114 ·Status: TERMINATED
-
PET MRI as a Staging Tool for Head and Neck Cancer
NCT04750434 ·Status: COMPLETED
-
PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma
NCT05662540 ·Status: RECRUITING ·Phase: NA
-
Molecular-Functional Imaging of Hypoxia in Childhood Sarcomas
NCT03054792 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
The Biodistribution and Potential Diagnostic Ability of 18F FACBC in Patients With Head and Neck, Breast, and Prostate Cancer
NCT00605488 ·Status: COMPLETED ·Phase: NA